The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 687-695

  Allouni, Zouhir E ^a   Gjerdet, Nils R ^a   Cimpan, Mihaela R ^a   Høl, Paul J ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adsorption; Cellular uptake; Nanoparticles; Proteins; Titanium dioxide

Indexed keywords

FIBRINOGEN; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN; NANOPARTICLE; TITANIUM DIOXIDE; PLASMA PROTEIN; TITANIUM;

ADSORPTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; HYDRODYNAMICS; IMAGING SYSTEM; L929 CELL LINE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; THERMAL ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; CYTOLOGY; FIBROBLAST; HUMAN; METABOLISM;

ADSORPTION; ANIMALS; BLOOD PROTEINS; FIBROBLASTS; HUMANS; MICE; NANOPARTICLES; PHOTOELECTRON SPECTROSCOPY; TITANIUM;

EID: 84921822990     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S72726     Document Type: Article

References (59)

1. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823-839.
2. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-627.
3. Cedervall T, Lynch I, Lindman S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007;104(7):2050-2055.
4. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle - protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci. 2007;134-135:167-174.
5. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell "sees" in bionanoscience. J Am Chem Soc. 2010;132(16):5761-5768.
6. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428-437.
7. Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.Expert Opin Drug Deliv. 2011;8(3):343-357.
8. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779-786.
9. Lynch I, Salvati A, Dawson KA. Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol. 2009;4(9):546-547.
10. Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today. 2008;3(1):40-47.
11. Dutta D, Sundaram SK, Teeguarden JG, et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci. 2007;100(1):303-315.
12. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials. 2009;30(4):603-610.
13. Johnston HJ, Semmler-Behnke M, Brown DM, Kreyling W, Tran L, Stone V. Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol Appl Pharmacol. 2010;242(1):66-78.
14. Guarnieri D, Guaccio A, Fusco S, Netti PA. Effect of serum proteins on polystyrene nanoparticle uptake and intracellular trafficking in endothelial cells. J Nanopart Res. 2011;13(9):4295-4309.
15. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012;6(7):5845-5857.
16. Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur J Pharm Biopharm. 2008;68(1):129-137.
17. Zhu Y, Li WX, Li QN, et al. Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles. Carbon. 2009;47(5):1351-1358.
18. Klinger A, Steinberg D, Kohavi D, Sela MN. Mechanism of adsorption of human albumin to titanium in vitro. J Biomed Mater Res. 1997;36(3):387-392.
19. 2. Biomaterials. 1991;12(6):593-596.
20. Yongli C, Xiufang Z, Yandao G, Nanming Z, Tingying Z, Xinqi S. Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles. J Colloid Interface Sci. 1999;214(1):38-45.
21. 2 particles. J Colloid Interface Sci. 1997;188(2):387-395.
22. Wassell DTH, Embery G. Adsorption of bovine serum albumin on to titanium powder. Biomaterials. 1996;17(9):859-864.
23. Zaqout MS, Sumizawa T, Igisu H, Higashi T, Myojo T. Binding of human serum proteins to titanium dioxide particles in vitro. J Occup Health. 2011;53(2):75-83.
24. Ruh H, Kühl B, Brenner-Weiss G, Hopf C, Diabaté S, Weiss C. Identification of serum proteins bound to industrial nanomaterials. Toxicol Lett. 2012;208(1):41-50.
25. 2 nanoparticles by fibroblasts. Toxicol In Vitro. 2012;26(3):469-479.
26. Boukha Z, Fitian L, López-Haro M, et al. Influence of the calcination temperature on the nano-structural properties, surface basicity, and catalytic behavior of alumina-supported lanthana samples. J Catalysis. 2010;272(1):121-130.
27. 2 nanoparticles in cell culture medium. Colloids Surf B Biointerfaces. 2009;68(1):83-87.
28. Bradford MM. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
29. Arvizo RR, Giri K, Moyano D, et al. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One. 2012;7(3):e33650.
30. Tkachenko NH, Yaremko ZM, Bellmann C. Effect of 1-1-charged ions on aggregative stability and electrical surface properties of aqueous suspensions of titanium dioxide. Colloid Surface A Physicochem Engineer Aspect. 2006;279(1):10-19.
31. Vainrub A, Pustovyy O, Vodyanoy V. Resolution of 90 nm (lambda/5) in an optical transmission microscope with an annular condenser. Opt Lett. 2006;31(19):2855-2857.
32. 2 with lower band gap showing high photocatalytic activity. Langmuir. 2004;20(7):2900-2907.
33. 2 photocatalysts synthesized via a sol-solvothermal process at a low temperature. J Solid State Chem. 2005;178(1):321-328.
34. Horie M, Nishio K, Fujita K, et al. Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem Res Toxicol. 2009;22(3):543-553.
35. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105(38):14265-14270.
36. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009;20(45):455101.
37. Landsiedel R, Ma-Hock L, Kroll A, et al. Testing metal-oxide nanomaterials for human safety. Adv Mater. 2010;22(24):2601-2627.
38. Taurozzi JS, Hackley VA, Wiesner MR. A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media. Nanotoxicology. 2013;7(4):389-401.
39. Vamanu CI, Høl PJ, Allouni ZE, Elsayed S, Gjerdet NR. Formation of potential titanium antigens based on protein binding to titanium dioxide nanoparticles. Int J Nanomedicine. 2008;3(1):69-74.
40. Rezwan K, Meier LP, Gauckler LJ. Lysozyme and bovine serum albumin adsorption on uncoated silica and AlOOH-coated silica particles: the influence of positively and negatively charged oxide surface coatings. Biomaterials. 2005;26(21):4351-4357.
41. Patil S, Sandberg A, Heckert E, Self W, Seal S. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials. 2007;28(31):4600-4607.
42. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small. 2009;5(6):701-708.
43. Li Y, Niu J, Zhang W, Zhang L, Shang E. Influence of aqueous media on the ROS-mediated toxicity of ZnO nanoparticles toward green fluorescent protein-expressing Escherichia coli under UV-365 irradiation. Langmuir. 2014;30(10):2852-2862.
44. Li Y, Zhang W, Niu J, Chen Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano. 2012;6(6):5164-5173.
45. Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol. 2009;6:35.
46. Iavicoli I, Leso V, Fontana L, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur Rev Med Pharmacol Sci. 2011;15(5):481-508.
47. Jin CY, Zhu BS, Wang XF, Lu QH. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol. 2008;21(9):1871-1877.
48. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol. 2006;40(14):4346-4352.
49. 2 nanoparticles: studies on a human monoblastoid cell line. Toxicol In Vitro. 2008;22(7):1689-1696.
50. 2 nanoparticles in living lung epithelial cells. Small. 2011;7(4):514-523.
51. Carlson C, Hussain SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608-13619.
52. Tenzer S, Docter D, Rosfa S, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5(9):7155-7167.
53. Zhang S, Nelson A, Beales PA. Freezing or wrapping: the role of particle size in the mechanism of nanoparticle-biomembrane interaction. Langmuir. 2012;28(35):12831-12837.
54. Muller KH, Motskin M, Philpott AJ, et al. The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages. Biomaterials. 2014;35(3):1074-1088.
55. Kendall M, Ding P, Kendall K. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Nanotoxicology. 2011;5(1):55-65.
56. Morrissey BW, Strömberg RR. Conformation of adsorbed blood proteins by infrared bound fraction measurements. J Colloid Interface Sci. 1974;46(1):152-164.
57. Fleischer CC, Payne CK. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res. 2014;47(8):2651-2659.
58. Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780-2799.
59. Ding HM, Ma YQ. Computer simulation of the role of protein corona in cellular delivery of nanoparticles. Biomaterials. 2014;35(30):8703-8710.